---
title: "Investors claim Xu Xiang, second-instance victory"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/224653921.md"
description: "Investors won the second-instance lawsuit in the securities market manipulation dispute with Xu Xiang and Xu Changjiang, the former chairman of WFDSJ. The Jiangsu Provincial High People's Court made a final ruling, and the plaintiffs received the civil judgment dated December 26, 2024, on January 10, 2025, marking a new development in the case"
datetime: "2025-01-11T12:26:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/224653921.md)
  - [en](https://longbridge.com/en/news/224653921.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/224653921.md)
generator: "portal-rs"
---

# Investors claim Xu Xiang, second-instance victory

Investors have won the second-instance lawsuit against "Private Placement King" Xu Xiang, former chairman of WFDSJ Xu Changjiang, and others for manipulating the securities market. According to Xu Feng, a lawyer from Shanghai Jiucheng Law Firm representing one of the plaintiffs, they received the civil judgment (2024) Su Min Zhong 1446 dated December 26, 2024, on January 10, 2025. The case of investors suing Xu Xiang, Xu Changjiang, WFDSJ, and others for securities market manipulation has made progress, with the Jiangsu Provincial High People's Court issuing a second-instance judgment, which is a final ruling. (China Fund News)

### Related Stocks

- [601010.CN](https://longbridge.com/en/quote/601010.CN.md)
- [600503.CN](https://longbridge.com/en/quote/600503.CN.md)

## Related News & Research

- [05:37 ETGan & Lee and Menarini Group Partner to Advance Bofanglutide in Europe](https://longbridge.com/en/news/297892423.md)
- [RISE Robotics Awarded $100,000 MassVentures Grant to Accelerate Commercialization of Beltdraulic Technology](https://longbridge.com/en/news/297642626.md)
- [HBO Max to Revamp Harry Potter Film Rewatch Podcast Into Companion Series for New TV Show (EXCLUSIVE)](https://longbridge.com/en/news/297675765.md)
- [Gentian Diagnostics to attend PReS meeting, spotlight circulating calprotectin testing in pediatric rheumatology](https://longbridge.com/en/news/297638164.md)
- [CRET: Q2 2026 saw higher sales and improved margins, but growth is limited by financing constraints](https://longbridge.com/en/news/297468890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**